Exact Mass: 396.0827
Exact Mass Matches: 396.0827
Found 66 metabolites which its exact mass value is equals to given mass value 396.0827,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
methyl (1R,2S)-2,5,7-trihydroxy-2-methyl-4,6,11-trioxo-1,2,3,4,6,11-hexahydrotetracene-1-carboxylate
methyl (1R,2S)-2,5,7-trihydroxy-2-methyl-4,6,11-trioxo-1,2,3,4,6,11-hexahydrotetracene-1-carboxylate
4H-Thieno(2,3-b)thiopyran-2-sulfonamide, 5,6-dihydro-6-(3-methoxypropyl)-4-(propylamino)-, 7,7-dioxide, (4S,6S)-
4H-Thieno(2,3-b)thiopyran-2-sulfonamide, 5,6-dihydro-6-(3-methoxypropyl)-4-(propylamino)-, 7,7-dioxide, (4S,6S)-
3,5,6-Trimethoxy-3,4-methylene-dioxyfurano[2,3:7,8]flavone
3,5,6-Trimethoxy-3,4-methylene-dioxyfurano[2,3:7,8]flavone
Me ester,di-Ac-3,8-Dihydroxy-1-methylanthraquinone-2-carboxylic acid
Me ester,di-Ac-3,8-Dihydroxy-1-methylanthraquinone-2-carboxylic acid
[4-(5,7-diacetyloxy-4-oxochromen-3-yl)phenyl] acetate
[4-(5,7-diacetyloxy-4-oxochromen-3-yl)phenyl] acetate
(2R,3S)-2-(3,4-dihydroxyphenyl)-3,5,9,10-tetrahydroxy-2,3-trans-3,4-dihydro-2H-benzofurano[2,3-h]chromene|gambircatechol
(2R,3S)-2-(3,4-dihydroxyphenyl)-3,5,9,10-tetrahydroxy-2,3-trans-3,4-dihydro-2H-benzofurano[2,3-h]chromene|gambircatechol
6,8-dimethoxy-7-(6?-methoxy-7?-coumarinyloxy)coumarin
6,8-dimethoxy-7-(6?-methoxy-7?-coumarinyloxy)coumarin
3-(1-Oxo-3-hydroxy-2-butenyl)-4,5-dihydroxy-9,10-dihydro-9,10-dioxoanthracene-2-acetic acid methyl ester
3-(1-Oxo-3-hydroxy-2-butenyl)-4,5-dihydroxy-9,10-dihydro-9,10-dioxoanthracene-2-acetic acid methyl ester
1,4,5-Triacetoxy-2-methyl-anthrachinon|1,4,5-triacetoxy-2-methyl-anthraquinone|islandicin peracetate|islandicin triacetate|Islandicintriacetat|Islanelicintriacetat|Tri-Ac-1,4,5-Trihydroxy-2-methylanthraquinone|Tri-O-acetyl-islandicin
1,4,5-Triacetoxy-2-methyl-anthrachinon|1,4,5-triacetoxy-2-methyl-anthraquinone|islandicin peracetate|islandicin triacetate|Islandicintriacetat|Islanelicintriacetat|Tri-Ac-1,4,5-Trihydroxy-2-methylanthraquinone|Tri-O-acetyl-islandicin
4-Demethyldehydropodophyllotoxin
9-Hydroxy-5-(4-hydroxy-3,5-dimethoxyphenyl)furo[3,4:6,7]naphtho[2,3-d][1,3]dioxol-6(8H)-one
Cys Cys Asp Gly
(3S)-3-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanamido]-3-[(carboxymethyl)carbamoyl]propanoic acid
Cys Cys Gly Asp
(2S)-2-{2-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanamido]acetamido}butanedioic acid
Cys Asp Cys Gly
(3S)-3-[(2R)-2-amino-3-sulfanylpropanamido]-3-{[(1R)-1-[(carboxymethyl)carbamoyl]-2-sulfanylethyl]carbamoyl}propanoic acid
Cys Asp Gly Cys
(3S)-3-[(2R)-2-amino-3-sulfanylpropanamido]-3-[({[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}methyl)carbamoyl]propanoic acid
Cys Gly Cys Asp
(2S)-2-[(2R)-2-{2-[(2R)-2-amino-3-sulfanylpropanamido]acetamido}-3-sulfanylpropanamido]butanedioic acid
Cys Gly Asp Cys
(3S)-3-{2-[(2R)-2-amino-3-sulfanylpropanamido]acetamido}-3-{[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}propanoic acid
Asp Cys Cys Gly
(3S)-3-amino-3-{[(1R)-1-{[(1R)-1-[(carboxymethyl)carbamoyl]-2-sulfanylethyl]carbamoyl}-2-sulfanylethyl]carbamoyl}propanoic acid
Asp Cys Gly Cys
(3S)-3-amino-3-{[(1R)-1-[({[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}methyl)carbamoyl]-2-sulfanylethyl]carbamoyl}propanoic acid
Asp Gly Cys Cys
(3S)-3-amino-3-[({[(1R)-1-{[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}-2-sulfanylethyl]carbamoyl}methyl)carbamoyl]propanoic acid
Gly Cys Cys Asp
(2S)-2-[(2R)-2-[(2R)-2-(2-aminoacetamido)-3-sulfanylpropanamido]-3-sulfanylpropanamido]butanedioic acid
Gly Cys Asp Cys
(3S)-3-[(2R)-2-(2-aminoacetamido)-3-sulfanylpropanamido]-3-{[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}propanoic acid
Gly Asp Cys Cys
(3S)-3-(2-aminoacetamido)-3-{[(1R)-1-{[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}-2-sulfanylethyl]carbamoyl}propanoic acid
(4,5-diacetyloxy-9,10-dioxoanthracen-2-yl)methyl acetate
(4,5-diacetyloxy-9,10-dioxoanthracen-2-yl)methyl acetate
N,N-diethyl-4-[(1-methylpyridin-1-ium-4-yl)diazenyl]aniline,iodide
N,N-diethyl-4-[(1-methylpyridin-1-ium-4-yl)diazenyl]aniline,iodide
5,6-Dihydro-6-(3-methoxypropyl)-4-(propylamino)-4H-thieno(2,3-b)thiopyran-2-sulfonamide 7,7-dioxide
5,6-Dihydro-6-(3-methoxypropyl)-4-(propylamino)-4H-thieno(2,3-b)thiopyran-2-sulfonamide 7,7-dioxide
3-(4-Fluorophenoxy)-6-methoxy-2-(4-methoxyphenyl)-1-benzothiophene 1-oxide
3-(4-Fluorophenoxy)-6-methoxy-2-(4-methoxyphenyl)-1-benzothiophene 1-oxide
Zinc;[amino-[2-[[5-[amino(azaniumylidene)methyl]benzimidazol-1-id-2-yl]methyl]benzimidazol-1-id-5-yl]methylidene]azanium
Zinc;[amino-[2-[[5-[amino(azaniumylidene)methyl]benzimidazol-1-id-2-yl]methyl]benzimidazol-1-id-5-yl]methylidene]azanium
methyl (1R,2R)-2,5,7-trihydroxy-2-methyl-4,6,11-trioxo-1,3-dihydrotetracene-1-carboxylate
methyl (1R,2R)-2,5,7-trihydroxy-2-methyl-4,6,11-trioxo-1,3-dihydrotetracene-1-carboxylate
2-[[5-(1H-benzimidazol-2-yl)-2-pyridinyl]thio]-N-(5-ethyl-1,3,4-thiadiazol-2-yl)acetamide
2-[[5-(1H-benzimidazol-2-yl)-2-pyridinyl]thio]-N-(5-ethyl-1,3,4-thiadiazol-2-yl)acetamide
1-[2-Furanyl(oxo)methyl]-6-(1-pyrrolidinylsulfonyl)-2-benzo[cd]indolone
1-[2-Furanyl(oxo)methyl]-6-(1-pyrrolidinylsulfonyl)-2-benzo[cd]indolone
N-[[2-cyanoethyl(methyl)amino]-sulfanylidenemethyl]-4-(4-morpholinylsulfonyl)benzamide
N-[[2-cyanoethyl(methyl)amino]-sulfanylidenemethyl]-4-(4-morpholinylsulfonyl)benzamide
5-(3-Methoxyphenyl)-1-(5-methyl-1,2-oxazol-3-yl)-4-(thiophene-2-carbonyl)pyrrolidine-2,3-dione
5-(3-Methoxyphenyl)-1-(5-methyl-1,2-oxazol-3-yl)-4-(thiophene-2-carbonyl)pyrrolidine-2,3-dione
[4,5-Dihydroxy-9,10-dioxo-3-(3-oxopentanoyl)-9,10-dihydroanthracen-2-yl]acetic acid
[4,5-Dihydroxy-9,10-dioxo-3-(3-oxopentanoyl)-9,10-dihydroanthracen-2-yl]acetic acid
Nogalaviketone
methyl (1R,2S)-2,5,7-trihydroxy-2-methyl-4,6,11-trioxo-1,2,3,4,6,11-hexahydrotetracene-1-carboxylate
A methyl ester derived from (1R,2S)-2,5,7-trihydroxy-2-methyl-4,6,11-trioxo-1,2,3,4,6,11-hexahydrotetracene-1-carboxylic acid.
PIT
PIT
PIT (2,2'-Pyridylisatogen tosylate) is a selective and non-competitive antagonist of P2Y1 receptor with an IC50 value of 0.14 μM for human P2Y1 receptor. PIT antagonizes P2Y1 receptor signaling without affecting nucleotide binding. PIT is an irreversible antagonist of responses to ATP at metabotropic purinoceptors (of the P2Y family) in some smooth muscles. PIT can be used for the research of chronic bronchitis and asthma[1][2][3].
10-hydroxy-16-(4-hydroxy-3,5-dimethoxyphenyl)-4,6,12-trioxatetracyclo[7.7.0.0³,⁷.0¹¹,¹⁵]hexadeca-1,3(7),8,10,15-pentaen-14-one
10-hydroxy-16-(4-hydroxy-3,5-dimethoxyphenyl)-4,6,12-trioxatetracyclo[7.7.0.0³,⁷.0¹¹,¹⁵]hexadeca-1,3(7),8,10,15-pentaen-14-one
2-(2h-1,3-benzodioxol-5-yl)-3,5,6-trimethoxyfuro[2,3-h]chromen-4-one
2-(2h-1,3-benzodioxol-5-yl)-3,5,6-trimethoxyfuro[2,3-h]chromen-4-one
7,10,15-trihydroxy-2,4,17-trimethyl-13,20-dioxapentacyclo[10.8.0.0²,⁹.0³,⁷.0¹⁴,¹⁹]icosa-1(12),4,9,14,16,18-hexaene-6,8,11-trione
7,10,15-trihydroxy-2,4,17-trimethyl-13,20-dioxapentacyclo[10.8.0.0²,⁹.0³,⁷.0¹⁴,¹⁹]icosa-1(12),4,9,14,16,18-hexaene-6,8,11-trione
5,8-bis(acetyloxy)-6-methyl-9,10-dioxoanthracen-1-yl acetate
5,8-bis(acetyloxy)-6-methyl-9,10-dioxoanthracen-1-yl acetate
anthraxin
NA
{"Ingredient_id": "HBIN016298","Ingredient_name": "anthraxin","Alias": "NA","Ingredient_formula": "C21H16O8","Ingredient_Smile": "CC(CC1=CC(=O)C2=C(O1)C=C(C3=C2OC(=CC3=O)C4=CC(=C(C=C4)O)O)O)O","Ingredient_weight": "396.3 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "1371","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "101515731","DrugBank_id": "NA"}
(7r)-7-methyl-6,8-dioxo-3-[(1e)-3-oxoprop-1-en-1-yl]isochromen-7-yl 2,4-dihydroxy-6-methylbenzoate
(7r)-7-methyl-6,8-dioxo-3-[(1e)-3-oxoprop-1-en-1-yl]isochromen-7-yl 2,4-dihydroxy-6-methylbenzoate
3-[2-(3,4-dihydroxyphenyl)ethenyl]-8,9-dihydroxy-6-methoxy-6h-pyrano[4,3-c]isochromen-1-one
3-[2-(3,4-dihydroxyphenyl)ethenyl]-8,9-dihydroxy-6-methoxy-6h-pyrano[4,3-c]isochromen-1-one
4-[5,7-bis(acetyloxy)-4-oxochromen-3-yl]phenyl acetate
4-[5,7-bis(acetyloxy)-4-oxochromen-3-yl]phenyl acetate
16-hydroxy-10-(4-hydroxy-3,5-dimethoxyphenyl)-4,6,13-trioxatetracyclo[7.7.0.0³,⁷.0¹¹,¹⁵]hexadeca-1,3(7),8,10,15-pentaen-12-one
16-hydroxy-10-(4-hydroxy-3,5-dimethoxyphenyl)-4,6,13-trioxatetracyclo[7.7.0.0³,⁷.0¹¹,¹⁵]hexadeca-1,3(7),8,10,15-pentaen-12-one
(6r)-3-[(1e)-2-(3,4-dihydroxyphenyl)ethenyl]-8,9-dihydroxy-6-methoxy-6h-pyrano[4,3-c]isochromen-1-one
(6r)-3-[(1e)-2-(3,4-dihydroxyphenyl)ethenyl]-8,9-dihydroxy-6-methoxy-6h-pyrano[4,3-c]isochromen-1-one
5,7-dihydroxy-13-methoxy-3,11,21,22-tetraoxaheptacyclo[10.9.1.1¹,⁶.1¹²,¹⁶.0²,⁴.0¹⁰,²⁴.0²⁰,²³]tetracosa-6(24),7,9,16,18,20(23)-hexaen-15-one
5,7-dihydroxy-13-methoxy-3,11,21,22-tetraoxaheptacyclo[10.9.1.1¹,⁶.1¹²,¹⁶.0²,⁴.0¹⁰,²⁴.0²⁰,²³]tetracosa-6(24),7,9,16,18,20(23)-hexaen-15-one
7-methyl-6,8-dioxo-3-(3-oxoprop-1-en-1-yl)isochromen-7-yl 2,4-dihydroxy-6-methylbenzoate
7-methyl-6,8-dioxo-3-(3-oxoprop-1-en-1-yl)isochromen-7-yl 2,4-dihydroxy-6-methylbenzoate
3-[(1e)-2-(3,4-dihydroxyphenyl)ethenyl]-8,9-dihydroxy-6-methoxy-6h-pyrano[4,3-c]isochromen-1-one
3-[(1e)-2-(3,4-dihydroxyphenyl)ethenyl]-8,9-dihydroxy-6-methoxy-6h-pyrano[4,3-c]isochromen-1-one
